FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

DSpace Repository

FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

Author: Hackenbruch, Christopher; Bauer, Jens; Heitmann, Jonas S.; Maringer, Yacine; Nelde, Annika; Denk, Monika; Zieschang, Lisa; Kammer, Christine; Federmann, Birgit; Jung, Susanne; Martus, Peter; Malek, Nisar P.; Nikolaou, Konstantin; Salih, Helmut R.; Bitzer, Michael; Walz, Juliane S.
Tübinger Autor(en):
Hackenbruch, Christopher
Bauer, Jens
Heitmann, Jonas S.
Maringer, Yacine
Nelde, Annika
Denk, Monika
Zieschang, Lisa
Kammer, Christine
Federmann, Birgit
Jung, Susanne
Martus, Peter
Nikolaou, Konstantin
Salih, Helmut R.
Bitzer, Michael
Walz, Juliane S.
Malek, Nisar Peter
Published in: Frontiers in Oncology (2024), Bd. 14, Article 1367450
Verlagsangabe: Lausanne : Frontiers Media Sa
Language: English
Full text: http://dx.doi.org/10.3389/fonc.2024.1367450
ISSN: 2234-943X
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)